Rymedi

Rymedi enables applications to collect data into meaningful and actionable information for end-users with respect to regulator audits, client reports, smart data analytics, and digital health, enabling clients to improve workflows and patient outcomes.

Blockchain Health Care Information Technology Medical Software Wellness

$9M

Latest Funding

Series A

Latest Funding Stage

2023-10-25

Funding Date

27

Employees

United States

Location

Greenville, South Carolina

City & State

Key Contacts
Unlock Contact Information

Upgrade to access founder details

Upgrade Now
Open Positions
View Careers Page
Unlock Tech Stack Data

Upgrade to access technology insights

Upgrade Now

Similar Startups

Archipelo
Archipelo  Logo

The Archipelo Developer Security Posture Management Platform provides organizations with—the underlying system of record to capture SDLC event data tied to developer actions. Archipelo empowers security, GRC, and engineering teams to proactively identify, triage, and mitigate risks before they impact your business.

Workhelix
Workhelix Logo

Workhelix brings together advanced research and comprehensive data to assess organizations' generative AI opportunities and which tasks can be accelerated with available technology, enabling businesses to navigate the opportunity landscape with data and reports, rather than relying on gut and instinct.

Subscript
Subscript  Logo

Subscript is a platform that allows users to develop, understand, and manage subscription businesses. This enables members to update the database, calculate measures such as ARR, net revenue retention, CAC, LTV, ARPA, and so on, and analyze customer segments.

Eikon Therapeutics
Eikon Therapeutics  Logo

Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.